David Curtelin

Dr. David Curtelin

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2015 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
DMDavid Morales-Alamo
David Morales-Alamo
JLJose Losa-Reyna
Jose Losa-Reyna
RTRafael Sánchez de Torres-Peralta
Rafael Sánchez de Torres-Peralta
MMMarcos Martin-Rincon
Marcos Martin-Rincon
MPMario Perez‐Valera
Mario Perez‐Valera
Jose A Lopez CalbetJose A Lopez Calbet
Jose A Lopez Calbet

10 February 2017 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
DCDavid Curtelin
David Curtelin
DMDavid Morales-Alamo
David Morales-Alamo
RTRafael Sánchez de Torres-Peralta
Rafael Sánchez de Torres-Peralta
PRPeter Rasmussen
Peter Rasmussen
MMMarcos Martin-Rincon
Marcos Martin-Rincon
Jose A Lopez CalbetJose A Lopez Calbet
Jose A Lopez Calbet
Cerebral blood flow (CBF) is regulated to secure brain O2 delivery while simultaneously avoiding hyperperfusion; however, both requisites may conflict during sprint exercise. To determine whether brain O2 delivery or CBF is prioritized, young men performed sprint exercise in normoxia and hypoxia (PIO2 = 73 mmHg). During the sprints, cardiac output increased to ∼22 L min−1, mean arterial pressure to ∼131 mmHg and peak systolic blood pressure ranged between 200 and 304 mmHg. Middle-cerebral artery velocity (MCAv) increased to peak values (∼16%) after 7.5 s and decreased to pre-exercise values towards the end of the sprint. When the sprints in normoxia were preceded by a reduced PETCO2, CBF and frontal lobe oxygenation decreased in parallel ( r = 0.93, P < 0.01). In hypoxia, MCAv was increased by 25%, due to a 26% greater vascular conductance, despite 4–6 mmHg lower PaCO2 in hypoxia than normoxia. This vasodilation fully accounted for the 22 % lower CaO2 in hypoxia, leading to a similar brain O2 delivery during the sprints regardless of PIO2. In conclusion, when a conflict exists between preserving brain O2 delivery or restraining CBF to avoid potential damage by an elevated perfusion pressure, the priority is given to brain O2 delivery.

7 June 2019 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Closed access
PDF file
MMMarcos Martin-Rincon
Marcos Martin-Rincon
JHJuan José González Henríquez
Juan José González Henríquez
JLJose Losa-Reyna
Jose Losa-Reyna
IPIsmael Perez‐Suarez
Ismael Perez‐Suarez
Jesús Ponce GonzálezJesús Ponce González
Jesús Ponce González
Jose A Lopez CalbetJose A Lopez Calbet
Jose A Lopez Calbet

6 February 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
MRMIRIAM GELABERT REBATO
MIRIAM GELABERT REBATO
JWJulia C. Wiebe
Julia C. Wiebe
MMMarcos Martin-Rincon
Marcos Martin-Rincon
VÁVíctor Galván Álvarez
Víctor Galván Álvarez
DCDavid Curtelin
David Curtelin
Jose A Lopez CalbetJose A Lopez Calbet
Jose A Lopez Calbet
The natural polyphenols mangiferin and luteolin have free radical-scavenging properties, induce the antioxidant gene program and down-regulate the expression of superoxide-producing enzymes. However, the effects of these two polyphenols on exercise capacity remains mostly unknown. To determine whether a combination of luteolin (peanut husk extract containing 95% luteolin, PHE) and mangiferin (mango leave extract (MLE), Zynamite®) at low (PHE: 50 mg/day; and 140 mg/day of MLE containing 100 mg of mangiferin; L) and high doses (PHE: 100 mg/day; MLE: 420 mg/day; H) may enhance exercise performance, twelve physically active men performed incremental exercise to exhaustion, followed by sprint and endurance exercise after 48 h (acute effects) and 15 days of supplementation (prolonged effects) with polyphenols or placebo, following a double-blind crossover design. During sprint exercise, mangiferin + luteolin supplementation enhanced exercise performance, facilitated muscle oxygen extraction, and improved brain oxygenation, without increasing the VO2. Compared to placebo, mangiferin + luteolin increased muscle O2 extraction during post-exercise ischemia, and improved sprint performance after ischemia-reperfusion likely by increasing glycolytic energy production, as reflected by higher blood lactate concentrations after the sprints. Similar responses were elicited by the two doses tested. In conclusion, acute and prolonged supplementation with mangiferin combined with luteolin enhances performance, muscle O2 extraction, and brain oxygenation during sprint exercise, at high and low doses.

8 June 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
MRMIRIAM GELABERT REBATO
MIRIAM GELABERT REBATO
JWJulia C. Wiebe
Julia C. Wiebe
MMMarcos Martin-Rincon
Marcos Martin-Rincon
NGNigel Gericke
Nigel Gericke
MPMario Perez-Valera
Mario Perez-Valera
Jose A Lopez CalbetJose A Lopez Calbet
Jose A Lopez Calbet
It remains unknown whether polyphenols such as luteolin (Lut), mangiferin and quercetin (Q) have ergogenic effects during repeated all-out prolonged sprints. Here we tested the effect of Mangifera indica L. leaf extract (MLE) rich in mangiferin (Zynamite®) administered with either quercetin (Q) and tiger nut extract (TNE), or with luteolin (Lut) on sprint performance and recovery from ischemia-reperfusion. Thirty young volunteers were randomly assigned to three treatments 48 h before exercise. Treatment A: placebo (500 mg of maltodextrin/day); B: 140 mg of MLE (60% mangiferin) and 50 mg of Lut/day; and C: 140 mg of MLE, 600 mg of Q and 350 mg of TNE/day. After warm-up, subjects performed two 30 s Wingate tests and a 60 s all-out sprint interspaced by 4 min recovery periods. At the end of the 60 s sprint the circulation of both legs was instantaneously occluded for 20 s. Then, the circulation was re-opened and a 15 s sprint performed, followed by 10 s recovery with open circulation, and another 15 s final sprint. MLE supplements enhanced peak (Wpeak) and mean (Wmean) power output by 5.0–7.0% (P < 0.01). After ischemia, MLE+Q+TNE increased Wpeak by 19.4 and 10.2% compared with the placebo (P < 0.001) and MLE+Lut (P < 0.05), respectively. MLE+Q+TNE increased Wmean post-ischemia by 11.2 and 6.7% compared with the placebo (P < 0.001) and MLE+Lut (P = 0.012). Mean VO2 during the sprints was unchanged, suggesting increased efficiency or recruitment of the anaerobic capacity after MLE ingestion. In women, peak VO2 during the repeated sprints was 5.8% greater after the administration of MLE, coinciding with better brain oxygenation. MLE attenuated the metaboreflex hyperpneic response post-ischemia, may have improved O2 extraction by the Vastus Lateralis (MLE+Q+TNE vs. placebo, P = 0.056), and reduced pain during ischemia (P = 0.068). Blood lactate, acid-base balance, and plasma electrolytes responses were not altered by the supplements. In conclusion, a MLE extract rich in mangiferin combined with either quercetin and tiger nut extract or luteolin exerts a remarkable ergogenic effect, increasing muscle power in fatigued subjects and enhancing peak VO2 and brain oxygenation in women during prolonged sprinting. Importantly, the combination of MLE+Q+TNE improves skeletal muscle contractile function during ischemia/reperfusion.

22 March 2021 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Closed access
PDF file
PPPablo B. Pedrianes-Martín
Pablo B. Pedrianes-Martín
MPMario Perez‐Valera
Mario Perez‐Valera
DMDavid Morales-Alamo
David Morales-Alamo
MMMarcos Martin-Rincon
Marcos Martin-Rincon
Ismael Perez-SuarezIsmael Perez-Suarez
Ismael Perez-Suarez
Jose A Lopez CalbetJose A Lopez Calbet
Jose A Lopez Calbet